J&amp;J, AbbVie's Imbruvica pads #CLL lead with FDA green light in younger patients. Has $JNJ and $ABBV positioned Imbruvica as the gold-standard for all CLL patient pools?
https://t.co/vehrytFQPB https://t.co/xVxDLCyi5Q